Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions
- 1 April 1990
- journal article
- research article
- Published by Springer Nature in In Vitro Cellular & Developmental Biology
- Vol. 26 (4) , 379-387
- https://doi.org/10.1007/bf02623829
Abstract
1,25-Dihydroxyvitamin D3 (1,25-(OH)2-D3) is known to decrease the proliferation and increase the differentiation of different cell types including human keratinocytes. The growth and differentiation of keratinocytes in the presence of 1,25-(OH)2-D3 using serum-free media formulations has been described previously. This investigation extends these studies to describe various culture conditions with human foreskin keratinocytes to determine the optimal antiproliferative activity of 1,25-(OH)2-D3. Keratinocytes were plated onto tissue culture dishes using one of three basic serum-free media protocols; a) with no feeder layer in keratinocyte growth medium (KGM); b) onto mitomycin C-treated 3T3 mouse embryo fibroblasts; or c) onto mitomycin C-treated dermal human fibroblasts. The last two protocols utilized Dulbecco's modified Eagle's Medium (DMEM) supplemented with growth factors. Keratinocyte cell growth was greatest in the KGM medium. Although the growth of keratinocytes on either feeder layer was similar, there were differences in the ability of the cells to form envelopes in the presence of 1,25-(OH)2-D3. The addition of hydrocortisone and cholera toxin to the medium also affected the response of the keratinocytes to 1,25-(OH)2-D3. The antiproliferative effect of 1,25-(OH)2-D3 was not altered by varying the extracellular calcium levels from 0.25 to 3 mM. The antiproliferative activity of 1,25-(OH)2-D3 is attenuated in cells at low density. Our results suggest that an optimal condition to investigate the ability of 1,25-(OH)2-D3 to inhibit keratinocyte proliferation is at preconfluent cell density in the presence of KGM supplemented with 1.5 mM calcium without a feeder layer. These conditions are not appropriate for investigating the enhancement of differentiation by 1,25-(OH)2-D3, but can be used to assay other agents that modulate keratinocyte proliferation.This publication has 46 references indexed in Scilit:
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- Acitretin versus etretinate in psoriasisJournal of the American Academy of Dermatology, 1988
- Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum‐free mediumJournal of Cellular Physiology, 1988
- Use of strontium to separate calcium‐dependent pathways for proliferation and differentiation in human keratinocytesJournal of Cellular Physiology, 1987
- Cellular confluence determines injury-induced prostaglandin E2 synthesis by human keratinocyte culturesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Three clonal types of keratinocyte with different capacities for multiplication.Proceedings of the National Academy of Sciences, 1987
- Extracellular calcium alters the effects of retinoic acid on DNA synthesis in cultured murine keratinocytesBiochemical and Biophysical Research Communications, 1986
- Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free mediaJournal of Tissue Culture Methods, 1985
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Hyperplasia in Confluent Cultures of Human KeratinocytesJournal of Investigative Dermatology, 1984
- The Photoproduction of 1α,25–Dihydroxyvitamin D3in SkinNew England Journal of Medicine, 1980